Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Normalizing drug-induced neuronal plasticity in nucleus accumbens weakens enduring drug-seeking behavior.

× No keyword cloud information.

6 in total

Review 1. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors: Rita Z Goldstein; Nora D Volkow
Journal: Am J Psychiatry Date: 2002-10 Impact factor: 18.112

Review 2. Structural plasticity associated with exposure to drugs of abuse.

Authors: Terry E Robinson; Bryan Kolb
Journal: Neuropharmacology Date: 2004 Impact factor: 5.250

Review 3. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission.

Authors: P W Kalivas; N Volkow; J Seamans
Journal: Neuron Date: 2005-03-03 Impact factor: 17.173

4. N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking.

Authors: Wenhua Zhou; Peter W Kalivas
Journal: Biol Psychiatry Date: 2007-08-24 Impact factor: 13.382

5. Cocaine regulates MEF2 to control synaptic and behavioral plasticity.

Authors: Suprabha Pulipparacharuvil; William Renthal; Carly F Hale; Makoto Taniguchi; Guanghua Xiao; Arvind Kumar; Scott J Russo; Devanjan Sikder; Colleen M Dewey; Maya M Davis; Paul Greengard; Angus C Nairn; Eric J Nestler; Christopher W Cowan
Journal: Neuron Date: 2008-08-28 Impact factor: 17.173

6. Altered dendritic spine plasticity in cocaine-withdrawn rats.

Authors: Hao-wei Shen; Shigenobu Toda; Khaled Moussawi; Ashley Bouknight; Daniel S Zahm; Peter W Kalivas
Journal: J Neurosci Date: 2009-03-04 Impact factor: 6.167

6 in total

3 in total

1. Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation.

Authors: Monica Luciana; Dustin Wahlstrom; James N Porter; Paul F Collins
Journal: Dev Psychol Date: 2012-03-05

Review 2. Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors: Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal: Neurotox Res Date: 2010-03-17 Impact factor: 3.911

Review 3. Cognitive enhancers in the treatment of substance use disorders: clinical evidence.

Authors: Kathleen T Brady; Kevin M Gray; Bryan K Tolliver
Journal: Pharmacol Biochem Behav Date: 2011-04-29 Impact factor: 3.533

3 in total